19-18597033-C-CG
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004750.5(CRLF1):c.713_714insC(p.Pro239AlafsTer91) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,612,466 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000032 ( 0 hom. )
Consequence
CRLF1
NM_004750.5 frameshift
NM_004750.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 8.88
Genes affected
CRLF1 (HGNC:2364): (cytokine receptor like factor 1) This gene encodes a member of the cytokine type I receptor family. The protein forms a secreted complex with cardiotrophin-like cytokine factor 1 and acts on cells expressing ciliary neurotrophic factor receptors. The complex can promote survival of neuronal cells. Mutations in this gene result in Crisponi syndrome and cold-induced sweating syndrome. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-18597033-C-CG is Pathogenic according to our data. Variant chr19-18597033-C-CG is described in ClinVar as [Pathogenic]. Clinvar id is 216913.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CRLF1 | NM_004750.5 | c.713_714insC | p.Pro239AlafsTer91 | frameshift_variant | 5/9 | ENST00000392386.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CRLF1 | ENST00000392386.8 | c.713_714insC | p.Pro239AlafsTer91 | frameshift_variant | 5/9 | 1 | NM_004750.5 | P1 | |
CRLF1 | ENST00000597131.1 | c.178_179insC | p.Pro61AlafsTer? | frameshift_variant | 2/4 | 2 | |||
CRLF1 | ENST00000684169.1 | c.713_714insC | p.Pro239AlafsTer91 | frameshift_variant | 5/9 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152020Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
10
AN:
152020
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000899 AC: 22AN: 244670Hom.: 0 AF XY: 0.0000749 AC XY: 10AN XY: 133598
GnomAD3 exomes
AF:
AC:
22
AN:
244670
Hom.:
AF XY:
AC XY:
10
AN XY:
133598
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1460328Hom.: 0 Cov.: 33 AF XY: 0.0000317 AC XY: 23AN XY: 726446
GnomAD4 exome
AF:
AC:
47
AN:
1460328
Hom.:
Cov.:
33
AF XY:
AC XY:
23
AN XY:
726446
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74370
GnomAD4 genome
AF:
AC:
10
AN:
152138
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cold-induced sweating syndrome 1 Pathogenic:2Other:1
Pathogenic, criteria provided, single submitter | clinical testing | UCLA Clinical Genomics Center, UCLA | Feb 11, 2014 | - - |
not provided, no classification provided | literature only | GeneReviews | - | Founder variant in the Roma population (Spain) - |
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2007 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2022 | The c.713dupC (p.P239Afs*91) alteration, located in exon 5 (coding exon 5) of the CRLF1 gene, consists of a duplication of C at position 713, causing a translational frameshift with a predicted alternate stop codon after 91 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the c.713dupC allele has an overall frequency of 0.01% (26/275984) total alleles studied. The highest observed frequency was 0.05% (17/35212) of Latino alleles. This variant has been reported in the homozygous and compound heterozygous states in individuals with CRLF1-related cold-induced sweating syndrome (Dagoneau, 2007; Aljabari, 2013; González Fernández, 2013; Piras, 2014). Based on the available evidence, this alteration is classified as pathogenic. - |
CRLF1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 24, 2024 | The CRLF1 c.713dupC variant is predicted to result in a frameshift and premature protein termination (p.Pro239Alafs*91). This variant was reported in the homozygous state in a family with Crisponi syndrome (Family 3 in Dagoneau et al. 2007. PubMed ID: 17436251), in the homozygous state in patients with cold-induced sweating syndrome (González Fernández et al. 2013. PubMed ID: 24008591; Herholz et al. 2011. PubMed ID: 21326283), and in the compound heterozygous state in a family with achalasia (Busch et al. 2017. PubMed ID: 27976805). Functional analysis showed that this variant disrupts CRLF1 secretion (Herholz et. 2011. PubMed ID: 21326283). This variant is reported in 0.048% of alleles in individuals of Latino descent in gnomAD. Frameshift variants in CRLF1 are expected to be pathogenic. Based on this evidence, this variant is interpreted as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 14, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 216913). This premature translational stop signal has been observed in individual(s) with clinical features of autosomal recessive cold-induced sweating syndrome (PMID: 17436251, 24488861, 27976805). This variant is present in population databases (rs768727082, gnomAD 0.05%). This sequence change creates a premature translational stop signal (p.Pro239Alafs*91) in the CRLF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CRLF1 are known to be pathogenic (PMID: 17436252, 19012339). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at